Jane Huang
2017 - BeiGene, Ltd.
In 2017, Jane Huang earned a total compensation of $3M as Chief Medical Officer at BeiGene, Ltd..
Compensation breakdown
| Bonus | $224,000 |
|---|---|
| Option Awards | $2,391,158 |
| Salary | $400,000 |
| Other | $8,100 |
| Total | $3,023,258 |
Huang received $2.4M in option awards, accounting for 79% of the total pay in 2017.
Huang also received $224K in bonus, $400K in salary and $8.1K in other compensation.
Rankings
In 2017, Jane Huang's compensation ranked 3,604th out of 14,666 executives tracked by ExecPay. In other words, Huang earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,604 out of 14,666 | 75th |
Division Manufacturing | 1,245 out of 5,770 | 78th |
Major group Chemicals And Allied Products | 351 out of 2,074 | 83rd |
Industry group Drugs | 270 out of 1,730 | 84th |
Industry Pharmaceutical Preparations | 213 out of 1,329 | 84th |
Source: SEC filing on April 30, 2018.
Huang's colleagues
We found five more compensation records of executives who worked with Jane Huang at BeiGene, Ltd. in 2017.
2017
John Oyler
BeiGene, Ltd.
Chief Executive Officer
2017
Howard Liang
BeiGene, Ltd.
Chief Financial Officer
2017
Amy Peterson
BeiGene, Ltd.
Chief Medical Officer
2017
Hematology Peterson
BeiGene, Ltd.
Chief Medical Officer
2017
Hematology Li
BeiGene, Ltd.
Executive Vice President Global Head of Business Development
News
Prelude Therapeutics CEO Krishna Vaddi's 2023 pay slips 20% to $2.6M
April 26, 2024
Prelude Therapeutics CEO Krishna Vaddi's 2022 pay falls 53% to $3.3M
April 28, 2023
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019